Sections

WG on Immunodeficiencies

Articles of great interest:

Clinical picture and treatment of 2212 patients with common variable
immunodeficiency.
Gathmann B, Mahlaoui N; CEREDIH, Gérard L, Oksenhendler E, Warnatz K,
Schulze I, Kindle G, Kuijpers TW; Dutch WID, van Beem RT, Guzman D, Workman
S, Soler-Palacín P, De Gracia J, Witte T, Schmidt RE, Litzman J, Hlavackova
E, Thon V, Borte M, Borte S, Kumararatne D, Feighery C, Longhurst H,
Helbert M, Szaflarska A, Sediva A, Belohradsky BH, Jones A, Baumann U,
Meyts I, Kutukculer N, Wågström P, Galal NM, Roesler J, Farmaki E,
Zinovieva N, Ciznar P, Papadopoulou-Alataki E, Bienemann K, Velbri S,
Panahloo Z, Grimbacher B; European Society for Immunodeficiencies Registry
Working Party.
J Allergy Clin Immunol. 2014 Jul;134(1):116-26.

A phenotypic approach for IUIS PID classification and diagnosis: guidelines
for clinicians at the bedside.
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles
C, Etzioni A, Fischer A, Franco JL, Geha RS, Hammarström L, Nonoyama S,
Ochs HD, Roifman CM, Seger R, Tang ML, Puck JM, Chapel H, Notarangelo LD,
Casanova JL.
J Clin Immunol. 2013 Aug;33(6):1078-87.

Primary immunodeficiency diseases: an update on the classification from the
international union of immunological societies expert committee forprimary
immunodeficiency.
Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME,
Cunningham-Rundles C, Etzioni A, Franco JL, Gaspar HB, Holland SM, Klein C,
Nonoyama S, Ochs HD, Oksenhendler E, Picard C, Puck JM, Sullivan K, Tang
ML.
Front Immunol. 2014 Apr 22;5:162.

Hyper-IgE syndromes: reviewing PGM3 deficiency.
Yang L, Fliegauf M, Grimbacher B.
Curr Opin Pediatr. 2014 Dec;26(6):697-703.

Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based
sensitization pattern.
Boos AC, Hagl B, Schlesinger A, Halm BE, Ballenberger N, Pinarci M, Heinz
V, Kreilinger D, Spielberger BD, Schimke-Marques LF, Sawalle-Belohradsky J,
Belohradsky BH, Przybilla B, Schaub B, Wollenberg A, Renner ED.
Allergy. 2014 Jul;69(7):943-53

Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair
immunity and increase serum IgE levels.
Sassi A, Lazaroski S, Wu G, Haslam SM, Fliegauf M, Mellouli F, Patiroglu T,
Unal E, Ozdemir MA, Jouhadi Z, Khadir K, Ben-Khemis L, Ben-Ali M,
Ben-Mustapha I, Borchani L, Pfeifer D, Jakob T, Khemiri M, Asplund AC,
Gustafsson MO, Lundin KE, Falk-Sörqvist E, Moens LN, Gungor HE, Engelhardt
KR, Dziadzio M, Stauss H, Fleckenstein B, Meier R, Prayitno K, Maul-Pavicic
A, Schaffer S, Rakhmanov M, Henneke P, Kraus H, Eibel H, Kölsch U, Nadifi
S, Nilsson M, Bejaoui M, Schäffer AA, Smith CI, Dell A, Barbouche MR,
Grimbacher B.
J Allergy Clin Immunol. 2014 May;133(5):1410-9

An update on the hyper-IgE syndromes.
Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B.
Arthritis Res Ther. 2012 Nov 30;14(6):228

Primary immune deficiencies with aberrant IgE production.
Ozcan E, Notarangelo LD, Geha RS.
J Allergy Clin Immunol. 2008 Dec;122(6):1054-62
Last updated 22 August 2015